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ABSTRACT The 2011 Escherichia coli outbreak in Germany, which resulted in more than 4,000 cases, including 908 cases of
hemolytic-uremic syndrome (HUS) and at least 50 deaths, highlighted the genome plasticity of E. coli and the potential for new
virulent strains to emerge. The analysis of 170 E. coli genome sequences for the presence of nine previously identiﬁed protective
extraintestinal pathogenic E. coli antigens suggested the feasibility of a combination vaccine as a universal intervention against
all pathogenic E. coli strains.
IMPORTANCE Thisarticlereportsonthefeasibilityofacombinationvaccineasauniversalinterventionagainstallpathogenic
Escherichia coli strains.
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E
scherichia coli is part of the human and animal commensal
ﬂora and lives in several different environments but is also a
well-knownpathogen.In2011,anoutbreakassociatedwithnewly
emergedpathogenicE.colioriginatedinGermanyandcaused908
cases of hemolytic-uremic syndrome (HUS) and 3,167 non-HUS
cases in Europe, leading to 50 deaths (1). Based on the site of
infection and disease caused by E. coli in humans, pathogenic
E. coli strains are divided into two major groups: extraintestinal
pathogenic E. coli (ExPEC) and intestinal pathogenic E. coli (In-
PEC). ExPEC strains are responsible for disease outside the intes-
tinal tract, such as urinary tract infections (UTIs), sepsis, and
meningitis, and are classiﬁed as uropathogenic E. coli (UPEC) or
neonatal meningitis-associated E. coli (NMEC). Among the In-
PECstrainscausingdiarrheagenicinfections,severalwell-deﬁned
pathotypes have been identiﬁed, including enteropathogenic
E.coli(EPEC),enterotoxigenicE.coli(ETEC),enterohemorrhagic
E. coli (EHEC), enteroaggregative E. coli (EAEC), enteroinvasive
E. coli (EIEC), and adherent-invasive E. coli (AIEC).
The strains responsible for the 2011 German outbreak belong
to the O104:H4 serotype and caused disease typical of EHEC in-
fections,whicharecharacterizedbydestructionofgutepithelium
cellsduetothereleaseofShigatoxin(Stx),resultinginabdominal
cramps, bloody diarrhea, and the triggering of HUS. However,
genome sequencing of the outbreak strains (LB226692, TY2482,
and H112180280) and multilocus sequence typing (MLST) anal-
ysisrevealedthattheyarecloselyrelatedtotheEAECstrain55989,
asshownbythelocalizationofthesestrainsonthesamebranchin
Fig. 1. EAEC strains use aggregative adherence ﬁmbriae (AAF) to
stimulate a strong interleukin-8 response and bioﬁlm formation
on the surface of epithelial cells, followed by disruption of the
actin cytoskeleton and exfoliation by Pet, which is a serine pro-
tease autotransporter of the Enterobacteriaceae (SPATE) (2).
The2011outbreakstrainsperfectlyillustratethegenomeplas-
ticityandevolutionofE.coliasaresultofhorizontalgenetransfer.
These strains combine the virulence mechanisms of two patho-
types(EAECandEHEC),leadingtoanimprovedabilitytoadhere
to and infect host cells. Furthermore, the acquisition of mecha-
nismsmediatingincreasedantibioticresistancehamperedpatient
treatment and recovery. These strains have conserved most of the
virulence factors of an EAEC strain, but several mobile genetic
elements (bacteriophages, plasmids, transposons, and pathoge-
nicity islands) were responsible for the acquisition of new attri-
butes, including the phage-mediated Stx2a, extended-spectrum
beta-lactamases, tellurite and mercury resistance genes, type IV
pilus system, colicin, hemolysin E, SPATE proteases, and F ﬁm-
briae, a system involved in high-frequency recombination, mobi-
lization, and transfer of genes (3, 4). In 2001, a similar O104:H4
strain, 01-09591, combining the features of EHEC and EAEC
pathotypesandexpressingbothAAFandStx,wasisolatedinGer-
many from patients with HUS (5).
For many years, E. coli pathotypes have been studied in isola-
tion instead of addressing E. coli as a single microorganism re-
sponsible for human and animal diseases. As seen by analysis of
the most recent outbreak strains, E. coli uses several mechanisms
toexchangegeneticmaterial,andnovelstrainsrepresentingcom-
binations of different pathotypes may emerge in the future. This
variability and adaptability reinforce the need for a novel ap-
proach to combat pathogenic E. coli. Considering the increasing
antibioticresistancepresentamongE.colistrains,whichisderived
from an uncontrolled use of antibiotics in humans and in the
veterinary ﬁeld, vaccination is the most promising approach to
controldisease.Comparativegenomeanalysisandreversevaccin-
ologyledtotheidentiﬁcationofnineantigenscapableofinducing
protective immune responses against ExPEC strains, several of
which are also prevalent in different intestinal E. coli pathotypes
(6). The feasibility of a universal intervention against all patho-
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E.colistrainssequencedtodatecouldbecoveredbyavaccinethat
contains at least four antigens: ECOK1_0290, ECOK1_3385,
ECOK1_3457, and c0975. The ﬁrst two of these antigens have
been further characterized, and ECOK1_0290 is a broadly con-
served adhesin, renamed FdeC (Factor adherence E. coli), that
elicits protection in mouse sepsis and mouse urinary tract infec-
tion models (6, 7). ECOK1_3385, a putative metalloprotease,
whichissurfaceexposedandissecretedbyanoveltypetwosecre-
tion system (T2SS), is able to confer nearly complete protection
from bacteremia and mortality in a murine model of sepsis after
either active or passive immunization (6). ECOK1_3457 is in-
FIG1 TheevolutionaryrelationshipanddistributionofprotectiveantigensamongsequencedE.colistrains.Theevolutionaryhistoryof170strainswasinferred
fromMLSTdatausingtheneighbor-joiningmethod.Thepresenceofnineprotectiveantigens,identiﬁedfromreversevaccinologyofExPECstrains,isshownas
colored squares, and they are sorted from the most represented (inner circle) to the least represented (outer circle). Strains were tentatively classiﬁed when
possible as InPEC (EHEC, ETEC, EIEC, EAEC, AIEC, and EPEC, colored as shown in the legend), ExPEC (NMEC, UPEC, and APEC), and mainly fecal or
environmental isolates (not colored).
Moriel et al.
2
® mbio.asm.org May/June 2012 Volume 3 Issue 3 e00118-12volved in iron acquisition (8), and c0975 is annotated as a hypo-
thetical protein. The ability of these antigens to also confer pro-
tection against intestinal pathotypes, the route of administration,
and the duration of the immune response will need further inves-
tigation.Inaddition,theeffectofvaccinatingwithantigens,which
in some cases are also present in E. coli commensals, on the com-
position of the natural intestinal ﬂora requires additional evalua-
tion. However, proteobacteria (including E. coli) represent less
than 0.1% of the human ﬂora (9).
In conclusion, we propose that E. coli should be treated as a
single microorganism capable of causing varied diseases in both
humans and animals. Despite the alternative mechanisms that
have evolved to colonize and adapt to new niches, E. coli strains
havemaintainedacoregenomesequenceandthereforesharesev-
eral components that could be useful targets for a universal vac-
cine against E. coli. From an evolutionary point of view, any com-
mensalorenvironmentalisolatehasthepotentialtoacquirenovel
virulencefactorsandbecomeapathogenicstrain,andthecontin-
uous exchange of genetic material between pathotypes could im-
pact the future coverage and efﬁcacy of a vaccine against E. coli.
Therefore, we need to consider E. coli as a microorganism that is
continuously evolving and look for highly represented antigens
that, in combination, could provide an effective vaccine that
would prevent outbreaks from occurring in the future.
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